Clinical manifestations of nonmotor symptoms in 1021 japanese Parkinson's disease patients from 35 medical centers

Abstract Introduction We aimed to investigate the prevalence and severity of nonmotor symptoms (NMSs) and to identify factors affecting NMSs and the health-related quality of life of Japanese patients with Parkinson's disease (PD). Methods A total of 1021 patients with PD who had one or more NM...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Parkinsonism & related disorders 2017-05, Vol.38, p.54-60
Hauptverfasser: Maeda, Tetsuya, MD, PhD, Shimo, Yasushi, MD, PhD, Chiu, Shih-Wei, MS, Yamaguchi, Takuhiro, PhD, Kashihara, Kenichi, MD, PhD, Tsuboi, Yoshio, MD, PhD, Nomoto, Masahiro, MD, PhD, Hattori, Nobutaka, MD, PhD, Watanabe, Hirohisa, MD, PhD, Saiki, Hidemoto, MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Introduction We aimed to investigate the prevalence and severity of nonmotor symptoms (NMSs) and to identify factors affecting NMSs and the health-related quality of life of Japanese patients with Parkinson's disease (PD). Methods A total of 1021 patients with PD who had one or more NMS and showed wearing-off under anti-parkinsonian treatment were enrolled from 35 medical centers in Japan for this observational study. The primary measurements were the Movement Disorder Society unified Parkinson's disease rating scale (MDS-UPDRS) part I and the Parkinson's Disease Questionnaire (PDQ-8). The relationships of MDS-UPDRS and PDQ-8 with the patient's clinical background and undertaken medical interventions were determined. Here, we report baseline data of our 52-week ongoing study. Results The mean MDS-UPDRS part I and PDQ-8 scores were 10.9 and 7.3, respectively. The most common NMSs were constipation problems (85.4%), sleep problems (73.7%), pain and other sensations (72.7%) and daytime sleepiness (72.0%). Fatigue was an NMS that affected 79.6% of females but only 72.6% of males, whereas features of dopamine dysregulation syndrome affected only 5.6% of females and 10.8% of males. Positive correlations were found between the MDS-UPDRS part I and the PDQ-8 (p 
ISSN:1353-8020
1873-5126
DOI:10.1016/j.parkreldis.2017.02.024